stockrow
Friday 6 November 2026
Export ASPI’s income statement to Excel — free account
ASP Isotopes Inc.
ASPI Basic Materials Specialty Chemicals
ASP Isotopes Inc.’s revenue for fiscal 2025 (year ended December 2025) was $23.8 million, up 475.5% from fiscal 2024.
- Revenue
- +327.6%
- EPS
- +73.8%
- Free cash flow
- −182.9%
- Total debt
- +162.4%
Quarter to June 2026, against a year earlier
1.94
0.22
+12.79%
Follow ASPI
Alert me
Target Price Range
Analyst price targets
Free accountTen years at a glance Fiscal years to December
| Ten-year view | Analyst estimates Powerpack | |||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Group | Line | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM Jun ’26 | Trend | 10 yrs | 2026e | 2027e | 2028e | Next 3/yr |
| Income, $m | ||||||||||||||||||
| Income, $m | Revenue | — | — | — | — | — | — | — | 0 | 4 | 24 | 31 | +642.1% | 0 | 0 | 0 | (91.5%) | |
| Gross margin, % | — | — | — | — | — | 0.00 | 0.00 | 32.10 | 38.59 | 14.28 | 18.32 | +14.3 pt | ||||||
| EBT | — | — | — | — | — | 0 | (5) | (16) | (32) | (160) | (137) | n/m | ||||||
| EBT margin, % | — | — | — | — | — | 0.00 | 0.00 | (3,764.50) | (779.73) | (669.05) | (443.39) | (669.0) pt | ||||||
| Net income | — | — | — | — | — | 0 | (5) | (16) | (32) | (160) | (117) | n/m | ||||||
| Per share, $ | ||||||||||||||||||
| Per share, $ | Revenue | — | — | — | — | — | 0.00 | 0.00 | 0.01 | 0.07 | 0.29 | 0.25 | n/m | |||||
| Earnings | — | — | — | — | — | (0.08) | (0.18) | (0.49) | (0.63) | (2.11) | (1.26) | +126.6% | ||||||
| Cash flow | — | — | — | — | — | 0.00 | (0.11) | (0.16) | (0.30) | (0.46) | (0.55) | n/m | ||||||
| Capex | — | — | — | — | — | 0.00 | (0.17) | (0.07) | (0.20) | (0.12) | (0.13) | n/m | ||||||
| Free cash flow | — | — | — | — | — | 0.00 | (0.28) | (0.23) | (0.50) | (0.57) | (0.68) | n/m | ||||||
| Book value | — | — | — | — | — | 0.17 | 0.37 | 0.57 | 0.92 | 3.17 | 2.24 | +106.4% | ||||||
| Shares, m | — | — | — | — | — | 34 | 27 | 33 | 56 | 83 | 104 | +24.7% | ||||||
| Valuation, × | ||||||||||||||||||
| Valuation, × | P/E | — | — | — | — | — | — | — | 0.00 | 0.00 | 0.00 | 0.00 | 0.0 | |||||
| P/S | — | — | — | — | — | — | — | 0.00 | 60.86 | 18.62 | 6.88 | 26.5 | ||||||
| P/B | — | — | — | — | — | — | — | 3.06 | 4.93 | 1.69 | 0.77 | 3.2 | ||||||
| EV/Sales | — | — | — | — | — | — | — | 0.00 | 54.70 | 13.36 | 7.03 | 22.7 | ||||||
| EV/FCF | — | — | — | — | — | — | — | (6.50) | (8.08) | (6.72) | (2.60) | (7.1) | ||||||
| Cash, $m | ||||||||||||||||||
| Cash, $m | Operating cash flow | — | — | — | — | — | 0 | (3) | (5) | (17) | (38) | (68) | n/m | |||||
| Capex | — | — | — | — | — | 0 | (4) | (2) | (11) | (10) | (16) | n/m | ||||||
| Free cash flow | — | — | — | — | — | 0 | (7) | (8) | (28) | (47) | (83) | n/m | ||||||
| Balance, $m | ||||||||||||||||||
| Balance, $m | Working capital | — | — | — | — | — | 3 | 1 | 5 | 59 | 367 | 202 | +234.9% | |||||
| Net debt | — | — | — | — | — | (2) | (2) | (7) | (26) | (115) | 4 | +173.2% | ||||||
| Shareholders’ equity | — | — | — | — | — | 6 | 10 | 19 | 51 | 263 | 275 | +157.3% | ||||||
| Returns, % | ||||||||||||||||||
| Returns, % | ROA | — | — | — | — | — | 0.00 | (50.36) | (81.35) | (57.62) | (59.12) | (37.30) | (59.1) pt | |||||
| ROIC | — | — | — | — | — | 0.00 | (38.84) | (86.43) | (64.22) | (25.32) | (22.17) | (25.3) pt | ||||||
| ROE | — | — | — | — | — | 0.00 | (62.54) | (113.70) | (100.33) | (111.50) | (87.13) | (111.5) pt | ||||||
| People | ||||||||||||||||||
| People | Employees | — | — | — | — | — | 4 | 4 | 76 | 136 | 271 | — | +186.9% | |||||
| Revenue/emp, $m | — | — | — | — | — | 0.00 | 0.00 | 0.01 | 0.03 | 0.09 | — | n/m | ||||||
Negative figures in brackets.
estimates
Fiscal years to Dec 2025 · latest quarter Jun 2026 · fundamentals updated 25 Oct 2026
ASP Isotopes Inc. vs peers in Specialty Chemicals (Q) = latest quarter vs a year earlier
| Company | Market cap | P/E | Fwd P/E | Revenue growth (Q) | EPS growth (Q) | FCF growth (Q) | Gross margin (Q) | EBIT margin (Q) | Compare |
|---|---|---|---|---|---|---|---|---|---|
| ASPN Aspen Aerogels, Inc. | $428.2M | — (loss-making) | — (loss-making) | +16.66% (above 0%: growing) | n/m | −93.09% (below 0%: shrinking) | 24.15% | (8.36%) | Compare |
| MNTK Montauk Renewables, Inc. | $343.0M | 38.8× | 16.6× | +19.71% (above 0%: growing) | n/m | +60.35% (above 0%: growing) | 100.00% | (0.14%) | Compare |
| GEVO Gevo, Inc. | $301.6M | — (loss-making) | — (loss-making) | +7.11% (above 0%: growing) | n/m | −167.47% (below 0%: shrinking) | 42.58% | (369.25%) | Compare |
| ALTO Alto Ingredients, Inc. | $284.7M | 5.4× | 9.7× | +12.48% (above 0%: growing) | n/m | +1,443.92% (above 0%: growing) | 6.77% | 3.51% | Compare |
| ASPI ASP Isotopes Inc. | $263.7M | — (loss-making) | — (loss-making) | +327.63% (above 0%: growing) | n/m | −182.92% (below 0%: shrinking) | 28.89% | (667.48%) | |
| FF FutureFuel Corp. | $236.9M | — (loss-making) | — (loss-making) | +120.69% (above 0%: growing) | n/m | +4,245.38% (above 0%: growing) | 19.08% | 14.29% | Compare |
| OEC Orion S.A. | $235.7M | — (loss-making) | — (loss-making) | +4.86% (above 0%: growing) | n/m | +64.87% (above 0%: growing) | 19.20% | 4.82% | Compare |
| CMT Core Molding Technologies Inc | $186.3M | 25.6× | 44.8× | +54.42% (above 0%: growing) | −18.18% (below 0%: shrinking) | −3,170.52% (below 0%: shrinking) | 14.83% | 1.76% | Compare |
| HDSN Hudson Technologies, Inc. | $172.1M | — (loss-making) | 33.2× | −19.71% (below 0%: shrinking) | −82.14% (below 0%: shrinking) | +43.42% (above 0%: growing) | 24.91% | 5.47% | Compare |
| Median of peers | $260.8M | 25.6× | 24.9× | +14.57% | — | +51.89% | 21.68% | 2.64% |
Pay and ownership Proxy statement filed 25 November 2025
Ownership
Directors and executive officers, together
14.40%
Paul Mann
7.30%
Ownership is the proxy’s own table: the directors and officers as a group, and every holder of 5% or more.
Read the proxy statement